Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]
Bio2RDF identifier
NCT00003960
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003960
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... who have hematologic cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2001-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... or this study within 3 years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
acute undifferentiated leukemia
adult acute lymphoblastic leukemia in remission
adult acute myeloid leukemia in remission
chronic phase chronic myelogenous leukemia
de novo myelodysplastic syndromes
previously treated myelodysplastic syndromes
refractory anemia with excess blasts in transformation
refractory anemia with excess blasts
refractory multiple myeloma
secondary acute myeloid leukemia
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-05-01T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003960
official title [clinicaltrials_vocabulary:official-title]
Matched Unrelated and Haploide ...... n for Hematologic Malignancies
org study id [clinicaltrials_vocabulary:org-study-id]
J9828 CDR0000067159
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2001-09-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
P30CA006973
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-04-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-05-01T00:00:00Z
identifier
clinicaltrials:NCT00003960
title
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
@en
type
label
Donor Bone Marrow Transplantat ...... r [clinicaltrials:NCT00003960]
@en